A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence)

White PL, Springer J, Wise MP, Einsele H, Loeffler C, Seif M, Prommersberger S, Backx M, Loffler J (2022)

Publication Type: Journal article

Publication year: 2022

Journal

Journal of Fungi MDPI

Book Volume: 8

Article Number: 81

Journal Issue: 1

DOI: 10.3390/jof8010081

Abstract

The COVID-19 pandemic has resulted in large numbers of patients requiring critical care management. With the established association between severe respiratory virus infection and invasive pulmonary aspergillosis (7.6% for COVID-19-associated pulmonary aspergillosis (CAPA)), the pandemic places a significant number of patients at potential risk from secondary invasive fungal disease. We described a case of CAPA with substantial supporting mycological evidence, highlighting the need to employ strategic diagnostic algorithms and weighted definitions to improve the accuracy in diagnosing CAPA.

Involved external institutions

University Hospital of Wales (UHW) GB United Kingdom (GB) Universitätsklinikum Würzburg DE Germany (DE) Cardiff and Vale University Health Board GB United Kingdom (GB)

How to cite

APA:

White, P.L., Springer, J., Wise, M.P., Einsele, H., Loeffler, C., Seif, M.,... Loffler, J. (2022). A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence). Journal of Fungi, 8(1). https://doi.org/10.3390/jof8010081

MLA:

White, P. Lewis, et al. "A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence)." Journal of Fungi 8.1 (2022).

BibTeX: Download